Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyVIARD, Jean-Paul ; SOUBERBIELLE, Jean-Claude ; MOCROFT, Amanda ; KIRK, Ole ; REEKIE, Joanne ; KNYSZ, Brygida ; LOSSO, Marcelo ; GATELL, Jose ; PEDERSEN, Court ; BOGNER, Johannes R ; LUNDGREN, Jens DAIDS (London), 2011-06, Vol.25 (10), p.1305-1315 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patientsMOCROFT, Amanda ; KIRK, Ole ; REISS, Peter ; DE WIT, Stephane ; SEDLACEK, Dalibor ; BENIOWSKI, Marek ; GATELL, Jose ; PHILLIPS, Andrew N ; LEDERGERBER, Bruno ; LUNDGREN, Jens DAIDS (London), 2010-07, Vol.24 (11), p.1667-1678 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antiviralsGrint, Daniel ; Peters, Lars ; Rockstroh, Juergen K ; Rakmanova, Aza ; Trofimova, Tatiana ; Lacombe, Karine ; Karpov, Igor ; Galli, Massimo ; Domingo, Pere ; Kirk, Ole ; Lundgren, Jens D ; Mocroft, AmandaAIDS (London), 2015-06, Vol.29 (10), p.1205-1215 [Periódico revisado por pares]England: Copyright Wolters Kluwer Health, IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin AmericaPodlekareva, D.N. ; Schultze, A. ; Panteleev, A. ; Skrahina, A.M. ; Miro, J.M. ; Rakhmanova, A. ; Furrer, H. ; Miller, R.F ; Efsen, A.M.W. ; Losso, M.H. ; Toibaro, J. ; Vassilenko, A. ; Girardi, E. ; Lundgren, J.D. ; Mocroft, A. ; Post, F.A. ; Kirk, O.AIDS (London), 2017-01, Vol.31 (3), p.375-384 [Periódico revisado por pares]England: Copyright Wolters Kluwer Health, IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trialPOZNIAK, Anton L ; MORALES-RAMIREZ, Javier ; BOVEN, Katia ; KATABIRA, Elly ; STEYN, Dewald ; LUPO, Sergio H ; SANTOSCOY, Mario ; GRINSZTEJN, Beatriz ; RUXRUNGTHAM, Kiat ; RIMSKY, Laurence T ; VANVEGGEL, SimonAIDS (London), 2010-01, Vol.24 (1), p.55-65 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patientsACHHRA, Amit C ; AMIN, Janaki ; LAW, Matthew G ; EMERY, Sean ; GERSTOFT, Jan ; CORDIN, Fred M ; VJECHA, Michael J ; NEATON, James D ; COOPER, David AAIDS (London), 2010-07, Vol.24 (12), p.1877-1886 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patientsPETERS, Lars ; GRINT, Daniel ; LUNDGREN, Jens D ; ROCKSTROH, Jürgen K ; SORIANO, Vincent ; REISS, Peter ; GRZESZCZUK, Anna ; SAMBATAKOU, Helen ; MOCROFT, Amanda ; KIRK, OleAIDS (London), 2012-09, Vol.26 (15), p.1917-1926 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trialWilkin, Aimee ; Pozniak, Anton L ; Morales-Ramirez, Javier ; Lupo, Sergio H ; Santoscoy, Mario ; Grinsztejn, Beatriz ; Ruxrungtham, Kiat ; Rimsky, Laurence T ; Vanveggel, Simon ; Boven, KatiaAIDS research and human retroviruses, 2012-05, Vol.28 (5), p.437-446 [Periódico revisado por pares]United StatesTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment-Naive, HIV-Infected Subjects: Week 48 Data from the Altair StudyPuls, Rebekah L. ; Srasuebkul, Preeyaporn ; Petoumenos, Kathy ; Boesecke, Christoph ; Duncombe, Chris ; Belloso, Waldo H. ; Molina, Jean-Michel ; Li, Lin ; Avihingsanon, Anchalee ; Gazzard, Brian ; Cooper, David A. ; Emery, SeanClinical infectious diseases, 2010-10, Vol.51 (7), p.855-864 [Periódico revisado por pares]Oxford: The University of Chicago PressTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
HIV resistance testing and detected drug resistance in EuropeSchultze, Anna ; Phillips, Andrew N ; Paredes, Roger ; Battegay, Manuel ; Rockstroh, Jürgen K ; Machala, Ladislav ; Tomazic, Janez ; Girard, Pierre M ; Januskevica, Inga ; Gronborg-Laut, Kamilla ; Lundgren, Jens D ; Cozzi-Lepri, AlessandroAIDS (London), 2015-07, Vol.29 (11), p.1379-1389 [Periódico revisado por pares]England: Copyright Wolters Kluwer Health, IncTexto completo disponível |